fig2
Figure 2. Proposed algorithm for management of patients with MetALD in clinical practice. ALD: Alcohol associated liver disease; EtG: ethyl glucuronide; FGF: fibroblast growth factor; GLP: glucagon-like peptide; MASLD: metabolic dysfunction-associated steatotic liver disease; MetALD: metabolic dysfunction and alcohol associated liver disease; PEth: phosphatidylethanol; T2DM: type 2 diabetes mellitus.
